SmHDM-1p146

General Information


DRACP ID  DRACP03830

Peptide Name   SmHDM-1p146

Sequence  IDTYSRKDDLDKKLLEVAKIIGRRLEKRHEYLAMK

Sequence Length  35

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C188H319N55O54S

Absent amino acids  CFNPQW

Common amino acids  K

Mass  485265

Pl  10.11

Basic residues  11

Acidic residues  7

Hydrophobic residues  11

Net charge  4

Boman Index  -10889

Hydrophobicity  -89.71

Aliphatic Index  103.14

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  2980

Absorbance 280nm  87.65

Polar residues  5

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23875042

Title  Cathelicidin-like helminth defence molecules (HDMs): absence of cytotoxic, anti-microbial and anti-protozoan activities imply a specific adaptation to immune modulation

Doi Not available

Year  2013

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  13417

DRACP is developed by Dr.Zheng's team.